D

DNALite Therapeutics, Inc.

6 employees

DNALite Therapeutics is an early-stage preclinical biotechnology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Therapy and Drug Delivery
Genetics
Health Care

Date founded

2016

Funding rounds raised

Total raised

$5.6M

from 14 investors over 14 rounds

D

DNALite Therapeutics, Inc. raised undisclosed on March 7, 2023

Investors: IndieBio and SOSV - The Accelerator VC

D

DNALite Therapeutics, Inc. raised $5.6M on April 14, 2022

Investors: IndieBio and SOSV - The Accelerator VC

D

DNALite Therapeutics, Inc. raised undisclosed on April 14, 2021

Investors: IndieBio and SOSV - The Accelerator VC

D

DNALite Therapeutics, Inc. raised undisclosed on June 6, 2019

Investors: IndieBio and SOSV - The Accelerator VC

D

DNALite Therapeutics, Inc. raised $1.5M on August 8, 2018

Investors: SOSV - The Accelerator VC, Blue Bear Ventures and Berkeley Catalyst Fund

D

DNALite Therapeutics, Inc. raised undisclosed on April 5, 2017

Investors: IndieBio and SOSV - The Accelerator VC

D

DNALite Therapeutics, Inc. raised undisclosed on January 1, 2016

Investors: CITRIS Foundry

FAQ